Free Trial

Vertex Pharmaceuticals (VRTX) Competitors

Vertex Pharmaceuticals logo
$473.96 -2.99 (-0.63%)
As of 03:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VRTX vs. AMZN, AXSM, CRSP, GOOG, ISRG, MRNA, RGEN, ABBV, LLY, and PFE

Should you be buying Vertex Pharmaceuticals stock or one of its competitors? The main competitors of Vertex Pharmaceuticals include Amazon.com (AMZN), Axsome Therapeutics (AXSM), CRISPR Therapeutics (CRSP), Alphabet (GOOG), Intuitive Surgical (ISRG), Moderna (MRNA), Repligen (RGEN), AbbVie (ABBV), Eli Lilly and Company (LLY), and Pfizer (PFE).

Vertex Pharmaceuticals vs. Its Competitors

Vertex Pharmaceuticals (NASDAQ:VRTX) and Amazon.com (NASDAQ:AMZN) are related large-cap companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

In the previous week, Amazon.com had 242 more articles in the media than Vertex Pharmaceuticals. MarketBeat recorded 281 mentions for Amazon.com and 39 mentions for Vertex Pharmaceuticals. Vertex Pharmaceuticals' average media sentiment score of 1.26 beat Amazon.com's score of 0.99 indicating that Vertex Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vertex Pharmaceuticals
35 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Amazon.com
178 Very Positive mention(s)
46 Positive mention(s)
32 Neutral mention(s)
13 Negative mention(s)
1 Very Negative mention(s)
Positive

Amazon.com has a net margin of 10.14% compared to Vertex Pharmaceuticals' net margin of -8.91%. Amazon.com's return on equity of 24.14% beat Vertex Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Vertex Pharmaceuticals-8.91% -3.36% -2.42%
Amazon.com 10.14%24.14%10.90%

Amazon.com has higher revenue and earnings than Vertex Pharmaceuticals. Vertex Pharmaceuticals is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vertex Pharmaceuticals$11.02B11.04-$535.60M-$3.92-120.91
Amazon.com$637.96B3.86$59.25B$6.1437.81

Vertex Pharmaceuticals currently has a consensus target price of $512.30, indicating a potential upside of 8.09%. Amazon.com has a consensus target price of $254.33, indicating a potential upside of 9.56%. Given Amazon.com's stronger consensus rating and higher possible upside, analysts clearly believe Amazon.com is more favorable than Vertex Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vertex Pharmaceuticals
0 Sell rating(s)
14 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.52
Amazon.com
0 Sell rating(s)
2 Hold rating(s)
45 Buy rating(s)
2 Strong Buy rating(s)
3.00

91.0% of Vertex Pharmaceuticals shares are owned by institutional investors. Comparatively, 72.2% of Amazon.com shares are owned by institutional investors. 0.2% of Vertex Pharmaceuticals shares are owned by insiders. Comparatively, 9.7% of Amazon.com shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Vertex Pharmaceuticals has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500. Comparatively, Amazon.com has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500.

Summary

Amazon.com beats Vertex Pharmaceuticals on 14 of the 17 factors compared between the two stocks.

Get Vertex Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRTX vs. The Competition

MetricVertex PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$121.65B$3.06B$5.67B$9.50B
Dividend YieldN/A2.44%4.05%4.00%
P/E Ratio-120.8520.8427.9420.01
Price / Sales11.04248.48396.9482.92
Price / CashN/A41.9636.1958.45
Price / Book7.448.308.645.84
Net Income-$535.60M-$55.19M$3.24B$258.42M
7 Day Performance2.31%5.18%3.27%2.14%
1 Month Performance5.26%17.74%10.83%12.25%
1 Year Performance-3.43%7.17%35.16%21.11%

Vertex Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRTX
Vertex Pharmaceuticals
4.3254 of 5 stars
$473.96
-0.6%
$512.30
+8.1%
-2.7%$121.65B$11.02B-120.856,100Positive News
AMZN
Amazon.com
4.3106 of 5 stars
$225.68
+0.3%
$249.42
+10.5%
+22.5%$2.40T$637.96B36.761,556,000Trending News
Upcoming Earnings
Analyst Forecast
Insider Trade
AXSM
Axsome Therapeutics
4.7254 of 5 stars
$112.27
+3.0%
$172.33
+53.5%
+24.2%$5.53B$385.69M-19.46380Analyst Revision
CRSP
CRISPR Therapeutics
1.7629 of 5 stars
$56.40
-0.7%
$71.75
+27.2%
+19.1%$4.87B$37.31M-12.48460Analyst Forecast
Analyst Revision
GOOG
Alphabet
4.6951 of 5 stars
$182.85
+0.8%
$207.13
+13.3%
+4.3%$2.22T$350.02B20.38190,200Trending News
Earnings Report
Analyst Forecast
Insider Trade
Options Volume
Analyst Revision
Gap Up
ISRG
Intuitive Surgical
4.6985 of 5 stars
$516.47
+0.9%
$592.86
+14.8%
+10.3%$185.11B$8.35B75.7315,638Trending News
Earnings Report
Analyst Forecast
MRNA
Moderna
4.2637 of 5 stars
$32.88
-2.3%
$46.61
+41.8%
-71.4%$12.73B$3.24B-3.775,800Analyst Forecast
RGEN
Repligen
4.6173 of 5 stars
$121.75
-6.5%
$170.75
+40.3%
-11.7%$6.84B$650.43M-270.551,778Upcoming Earnings
Analyst Upgrade
Analyst Revision
ABBV
AbbVie
4.8912 of 5 stars
$191.54
-0.5%
$211.29
+10.3%
+9.9%$338.33B$56.33B81.5055,000Positive News
Upcoming Earnings
LLY
Eli Lilly and Company
4.9838 of 5 stars
$799.51
+0.8%
$1,012.56
+26.6%
-9.2%$757.72B$49.00B65.0547,000Trending News
PFE
Pfizer
4.9792 of 5 stars
$25.36
-1.2%
$28.55
+12.6%
-14.1%$144.15B$62.46B18.3781,000Positive News

Related Companies and Tools


This page (NASDAQ:VRTX) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners